BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 327115)

  • 1. [Studies on the step-wise extraction of BCG cell surface components and immunological properties of the extracts].
    Shimono T
    Nihon Saikingaku Zasshi; 1977 Mar; 32(2):369-91. PubMed ID: 327115
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE; Meyer TJ; Azuma I; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological properties of cellular membranes of Mycobacterium bovis].
    Romanova RIu; Pavlova VT; Il'ina IN; Kliuev VA
    Probl Tuberk; 1978 Aug; (8):67-70. PubMed ID: 360207
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross reactivity of Mycobacterium laprae and BCG. A report on further studies.
    Goihman-Yahr M; Convit J
    Int J Lepr Other Mycobact Dis; 1972; 40(1):62-7. PubMed ID: 4562385
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical and biological properties of hydrosoluble fraction of BCG.
    Sato H; Yokosawa A; Arai H; Motomiya M; Kurita K
    Sci Rep Res Inst Tohoku Univ Med; 1975 Dec; 22(3-4):33-7. PubMed ID: 772805
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.
    Meyer TJ; Azuma I; Ribi EE
    Immunology; 1975 Feb; 28(2):219-29. PubMed ID: 804436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical synthesis and immunologic activities of the active unit of BCG-CWS].
    Saiki I; Azuma I
    Nihon Rinsho; 1981 Apr; 39(4):1861-7. PubMed ID: 7031298
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
    McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
    Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunotherapy of cancer with BCG].
    Yamamura Y; Azuma I
    Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of guinea pig macrophages by cell walls of Mycobacterium bovis, strain BCG.
    Kelly MT
    Cell Immunol; 1976 Oct; 26(2):254-63. PubMed ID: 824056
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical structure of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG.
    Petit JF; Wietzerbin J; Das BC; Lederer E
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):118-25. PubMed ID: 126548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    Zbar B; Rapp HJ; Ribi EE
    J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
    Yamamoto K
    Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunochemistry of tubercle bacilli, with special reference to adjuvant activity (author's transl)].
    Azuma I
    Kekkaku; 1981 Dec; 56(12):595-607. PubMed ID: 7035731
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some immunological and toxic properties of mycobacteria grown in vivo.
    Kondo E; Kanai K
    Jpn J Med Sci Biol; 1974 Feb; 27(1):53-7. PubMed ID: 4600526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.